Who we are

Owen Mumford specialises in integrated design and build services from a broad range of self-injection platform devices for the pharmaceutical industry.

From the first automatic lancing device to our patented self-injection devices, with Owen Mumford you have access to unrivalled experience in designing, developing and delivering solutions to help you make adherence easier for patients.


With more than 65 years’ experience, your device is in trusted hands with Owen Mumford.

From day one, we will guide you throughout the development process; at every step, you will benefit from professional and supportive project management, processes, industrialisation and production for a smooth development and launch.

The springless, passive safety device for pre-filled syringes

Fully designed, developed and ready for commercial supply

Comfort

Large, ergonomic plunger head and a smooth, integrated finger flange, resulting in an integrated look and feel.

Secure plunger

Plunger cannot detach when removing the RNS.

Reduced risk

No compromise to sterility in assembly – plunger does not touch the bung.

User confidence

Syringe barrel is unobscured, allowing the user to check the contents of the syringe, and to confirm the full dose has been delivered.

Reliability

Prevention of occidental activation e.g. in transit.

Simple 2-step final sembly

Final assembly process is simple and outside of the sterile filling area.

Cost effective

Designed to work with standard, pre-filled syringes which means no change to existing primary container and minimises training costs.

Passive safety

Passive needle retraction means that the device is safe as soon as the plunger is fully depressed

Self-Injection Device Solutions 

Ensuring that patients are willing and able to inject their medication is key to their well-being. As pioneers in self-injection technologies, our experience enables us to effectively work with you to find the right drug delivery solution.


Please visit: omdevicesolutions.com

Go to article: Home | Advancing adherenceGo to article: Scandinavian Health Company InsightGo to article: Scandinavian Health Ltd.Go to article: EditorialGo to article: PfanstiehlGo to article: Pfanstiehl Company InsightGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: Owen MumfordGo to article: NewsGo to article: TSS Company InsightGo to article: TSS ABGo to article: Novo NordiskGo to article: The pharma industry briefingGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CRO GmbHGo to article: Timeline: using viruses to fight diseaseGo to article: Swiss WorldCargoGo to article: AirBridgeCargo Company InsightGo to article: AirBridgeCargoGo to article: Q&A: an eye on innovation with SparingVisionGo to article: MasterpackGo to article: Molnar Company InsightGo to article: MolnarGo to article: B&W TekGo to article: Could smart pill bottles dispense a solution to drug non-adherence?Go to article: Hapa Company InsightGo to article: Qatar AirwaysGo to article: Dow EuropeGo to article: WHO’s Essential Medicines List: discussing innovation and accessGo to article: Erdmann Design SwitzerlandGo to article: AEB Company Insight Go to article: AEBGo to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: Are we nearing the end of animal testing in pharma?Go to article: ImmuMap Company Insight Go to article: ImmuMapGo to article: Barc Lab Go to article: Why is pharma so bad at sharing clinical trial data?Go to article: SmartCAE Company InsightGo to article: SmartCAEGo to article: Capsugel Company InsightGo to article: Unseen genes: boosting African DNA in medical researchGo to article: Emirates SkyCargoGo to article: Pfeiffer VacuumGo to article: Could Netflix-style subscription models work for medicines?Go to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: MicronovaGo to article: AlpexGo to article: EventsGo to article: Senn Chemicals Company InsightGo to article: Senn ChemicalsGo to article: ICCI Company InsightGo to article: ICCIGo to article: Next issueGo to article: CBDepot Company InsightGo to article: CBDepotGo to article: Nemera Company InsightGo to article: NemeraGo to article: Komtur Pharmaceuticals Company InsightGo to article: Komtur PharmaceuticalsGo to article: MimotopesGo to article: Baxter